Perioperative fibrinolytic activity in cholecystectomized patients the postoperative fibrinolytic shutdown is only a temporary event

Fibrinolysis and Proteolysis

Volumn 13, Issue 3, 1999, Pages 118-123

  Szczepanski M ^a,c   Kucharski, W ^b   Ratajczak, J ^b   Meissner, A J ^b  

^a Medical Center of Postgraduate Education   (Poland)

^b INSTITUTE OF HEMATOLOGY AND TRANSFUSION MEDICINE   (Poland)

^c Laboratory of Hemostasis   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

PLASMINOGEN; TISSUE PLASMINOGEN ACTIVATOR;

ABDOMINAL SURGERY; ADULT; AGED; ARTICLE; BLOOD CLOT LYSIS; CHOLECYSTECTOMY; CLINICAL ARTICLE; COMPLEX FORMATION; ENDOTHELIUM CELL; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBRINOLYSIS; HUMAN; LABORATORY TEST; MALE; PERIOPERATIVE PERIOD; PERITONEAL CAVITY; PRIORITY JOURNAL; PROSPECTIVE STUDY;

EID: 0032793942     PISSN: 13690191     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0268-9499(99)90098-X     Document Type: Article

References (36)

1. Chakrabarti R, Hocking ED, Fearnley GR. Reaction pattern to three stresses - electroplexy, surgery, and myocardial infarction - of fibrinolysis and plasma fibrinogen. J Clin Pathol 1969; 22: 659-662.
2. Mansfield AO. Alteration in fibrinolysis associated with surgery and venous thrombosis. Brit J Surg 1972; 59: 754-757.
3. MacIntyre IMG, Webber RG, Crispin JR et al. Plasma fibrinolysis and postoperative deep vein thrombosis. Brit J Surg 1976; 63: 694-697
4. Knight MTN, Dawson R, Melrose DG. Fibrinolytic response to surgery. Lancet 1977; 2: 370-373.
5. Paramo JA, Alfaro MJ, Rocha E. Postoperative changes in the plasmatic levels of tissue-type plasminogen activator and its fast-acting inhibitor - relationship to deep vein thrombosis and influence of prophylaxis. Thromb Haemostas 1985; 54: 713-716.
6. Aranda A, Paramo JA, Rocha E. Fibrinoiytic activity in plasma after gynecological and urological surgery. Haemostasis 1988; 18: 129-134.
7. Tsuji K, Eguchi Y, Kodama M. Postoperative hypercoagulable state followed by hyperfibrinolysis related to wound healing after hepatic resection. J Amer Coll Surg 1996; 183: 230-238.
8. Kluft C. Fibrinolytic shut-down after surgery. In: Sawaya R (ed.) Fibrinolysis and the central nervous system, Philadelphia: Haley and Belfus, 1990; 127-140.
9. Koh SCL, Pua HL, Tay DHB et al. The effects of gynaecological surgery on fibrinolysis, fibrinolytic inhibitor and the haemostatic status as assessed by thromboelastography. Thromb Haemostas 1995; 73: 1138 (abstr 912)
10. Dexter SPL, Griffith JP, Grant PJ, McMahon MJ. Activation of coagulation and fibrinolysis in open and laparoscopic cholecystectomy. Surg Endosc 1996; 10: 1069-1074.
11. Szczepański M, Duchiński T, Kretowicz P. Single dose of nandrolone does not prevent postoperative fibrinolytic shutdown. Fibrinolysis 1995; 9: 350-355.
12. Ygge J. Changes in blood coagulation and fibrinolysis during the postoperative period. Amer J Surg 1970; 119: 225-232.
13. Mellbring G, Dahlgren S, Reiz S, Wiman B. Fibrinolytic activity in plasma and deep vein thrombosis after major abdominal surgery. Thromb Res 1983; 32: 575-584.
14. D'Angelo D, Kluft C, Verheijen JH et al. Fibrinolytic shut-down after surgery: impairment of the balance between tissue-type plasminogen activator and its specific inhibitor. Eur J Clin Invest 1985; 15: 308-312.
15. Salonen E, Saksela T, Vartio T et al. Plasminogen and tissue-type plasminogen activator bind to immobilized fibronectin. J Biol Chem 1985; 260: 12302-12307.
16. Silverstein R, Harpel PC, Nachman RL. Tissue plasminogen activator and urokinase enhance the binding of plasminogen to thrombospondin. J Biol Chem 1986; 261: 9959-9965.
17. Hajjar KA, Harpel PC, Jaffe EA, Nachman RL. Binding of plasminogen to cultured human endothelial cells. J Biol Chem 1986; 261: 11656-11662.
18. Knudsen B, Silverstein R, Leung L et al. Binding of plasminogen to extracellular matrix. J Biol Chem 1986; 261: 10765-10771.
19. Ivarsson M-L, Holmdahl L, Eriksson E, Soderberg R, Risberg B. Expression and kinetics of fibrinolytic components in plasma and peritoneum during abdominal surgery. Fibrinolys Proteolys 1998; 12: 61-67.
20. Kluft C, Verheijen JH, Jie AFH, Rijken DC et al. The postoperative fibrinolytic shutdown: a rapidly reverting acute phase pattern for the fast-acting inhibitor of tissue-type plasminogen activator after trauma. ScandJ Clin Lab Invest 1985; 45: 605-610.
21. Mellbring G, Dahlgren S, Wiman B. Plasma fibrinolytic activity in patients undergoing major abdominal surgery. Acta Chir Scand 1985; 151: 109-114.
22. Dabrowiecki S, Rość D, Jurkowski P. The influence of laparoscopic cholecystectomy on perioperative blood clotting and fibrinolysis. Blood Coag Fibrinolys 1997; 8: 1-5.
23. Mellbring G, Nilsson T, Bergsdorf N, Wallen P. Tissue plasminogen activator concentration in major abdominal surgery. Thromb Res 1984; 36: 331-334.
24. Merlo G, Fansone G, Barbero C, Castagna B. Fibrinolytic activity of the human peritoneum. Eur Surg Res 1980; 12: 433-438.
25. van Hinsbergh VWM, Kooistra T, Scheffer MA et al. Characterization and fibrinolytic properties of human omental tissue mesothelial cells. Comparison with endothelial cells. Blood 1990; 75: 1490-1497
26. Scott-Coombes DM, Whawell SA, Thompson JN. The operative peritoneal fibrinolytic response to abdominal operation. Eur J Surg 1995; 161: 395-399.
27. Holmdahl L, Eriksson E, Al-Jabreen M, Risberg B. Fibrinolysis in human peritoneum during operation. Surgery 1996; 119: 701-705.
28. Aberg M, Nilsson IM. Fibrinolytic activity of the vein wall after surgery. Brit J Surg 1978; 65: 259-262.
29. Ljungner H, Bergqvist D, von Hebel J, Isacson S. Influence of major surgery on plasminogen activator activity in superficial hand veins. Eur Surg Res 1983; 15: 161-167.
30. Noordhoek Hegt V. Distribution and variation of fibrinolytic activity in the walls of human arteries and veins. Haemostasis 1976; 5: 355-372.
31. Lijnen HR, Collen D. Endothelium in hemostasis and thrombosis. Prog Cardiovasc Dis 1997; 39: 343-350.
32. Juhan-Vague J, Ailland MF, DeCock F. et al. The fast-acting inhibitor of tissue-type plasminogen activator is an acute phase reactant protein. Davidson JF, Donati MB, Cocheri S (eds.) Progress in fibrinolysis, vol. 7. Edinburgh: Churchill Livingstone, 1985; 146-149.
33. Szczepański M, Kubiak J, Lembas L. Postoperative injection of phenylbutazone does not influence fibrinolytic shutdown. Curr Med Res Opinion 1998; 14: 105-110.
34. Francis WC, Marder VJ. Physiologic regulation and pathologic disorders of fibrinolysis. In: Colman RW, Hirsh J, Marder VJ, Salzman EW, (eds.) Hemostasis and thrombosis. Basic principles and clinical practice, 3rd edn. Philadelphia: JB Lippincot, 1994.
35. Psuja P, Zozulihska M, Tokarz A, Zawilska. Fibrinolytic suppresion in patients after minor abdominal surgery. Brit J Haemat 1994; 87 (suppl 1): 185 (abstr 721).
36. Lopez Y, Paramo JA, Valenti JR et al. Hemostatic markers in surgery: a different fibrinolytic activity may be of pathophysiological significance in orthopedic versus abdominal surgery. Int J Clin Lab Res 1997; 27: 233-237